Pro-inflammatory cytokine, matrix metalloproteinases and TIMP-1 are involved in wound healing after mastectomy in invasive breast cancer patients

Biomedicine and Pharmacotherapy

Volumn 61, Issue 9 SPEC. ISS., 2007, Pages 548-552

  Loo, Wings T Y ^a,b   Sasano, H ^a   Chow, Louis W C ^b  

^a TOHOKU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b UNIMED Medical Institute   (Hong Kong)

Author keywords

Flap necrosis; Interleukin 6; Matrix metalloproteinases; P selectin; Seroma

Indexed keywords

CYTOKINE; GELATINASE A; GELATINASE B; INTERLEUKIN 6; MATRIX METALLOPROTEINASE; PADGEM PROTEIN; TISSUE INHIBITOR OF METALLOPROTEINASE 1;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER INVASION; CLINICAL ARTICLE; CORRELATION ANALYSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GRAFT NECROSIS; HUMAN; INFECTION; INFLAMMATION; KINETICS; MASTECTOMY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; SEROMA; WOUND HEALING;

EID: 35248822806     PISSN: 07533322     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biopha.2007.08.012     Document Type: Article

References (34)

1. Baker E.A., and Leaper D.J. Proteinases, their inhibitors, and cytokine profiles in acute wound fluid. Wound Repair and Regeneration 8 (2000) 392-398
2. Ley K. Functions of selectins. Results and Problems in Cell Differentiation 33 (2001) 177-200
3. Bachmann L., Dressler J., Koch R., and Muller E. Enhanced expression of selectins in human skin wounds. International Journal of Legal Medicine 112 (1999) 39-44
4. Gallucci R.M., Guriel J.L., Kommineni C., Luster M.I., Matheson J.M., Simeonova P.P., et al. Impaired cutaneous wound healing in interleukin-6-deficient and immunosuppressed mice. Federation of American Societies for Experimental Biology 14 (2000) 2525-2531
5. Griffiths T.A., Stoner M., and Wood F. Epidermal-derived factors in the treatment of a chronic leg ulcer. Journal of Wound Care 6 (1997) 256-258
6. Calvano S.E., Lin E., and Lowry S.F. Inflammatory cytokines and cell response in surgery. Surgery 127 (2000) 117-126
7. Fu X., Hsu S., Sheng Z., Tian H., and Wang D. In vivo effects of tumor necrosis factor-alpha on incised wound and gunshot wound healing. The Journal of Trauma 40 (1996) S140-S143
8. Alam H.B., Bonnet I., Kim D., Kirkpatrick J.R., and Provido H. Acquired immunity to TNF: effects on intestinal wound healing. Journal of Surgical Research 62 (1996) 251-254
9. Abe H., diZerega G.S., Ellefson D., and Rodgers K.E. Kinetics of interleukin-1 and tumor necrosis factor secretion by rabbit macrophages recovered from the peritoneal cavity after surgery. Journal of Investigative Surgery 4 (1991) 141-151
10. Cooney R.N., Ehrlich H.P., Maish G.O., and Shumate M.L. Tumor necrosis factor binding protein improves incisional wound healing in sepsis. Journal of Surgical Research 78 (1998) 108-117
11. Berendes E., Böcker D., Rothenburger M., Scheld H.H., Schmid C., Schneider M., et al. The impact of the pro- and anti-inflammatory immune response on ventilation time after cardiac surgery. Cytometry. Part B, Clinical Cytometry 53B (2003) 70-74
12. Denhardt D.T., Khokha R., Lala P., Waterhouse P., and Zimmer M. Increased proteinase expression during tumor progression of cell lines down-modulated for TIMP levels: a new transformation paradigm. Journal of Cancer Research and Clinical Oncology 117 (1991) 333-338
13. Agren M.S., Andersen M., Gottrup F., Jorgensen L.N., and Viljanto J. Matrix metalloproteinase 9 level predicts optimal collagen deposition during early wound repair in humans. British Journal of Surgery 85 (1998) 68-71
14. Benaud C., Dickson R.B., and Thompson E.W. Roles of the matrix metalloproteinases in mammary gland development and cancer. Breast Cancer Research and Treatment 50 (1998) 97-116
15. Kahari V.M., and Ravanti L. Matrix metalloproteinases in wound repair. International Journal of Molecular Medicine 6 (2000) 391-407
16. Liang H.X., Nwomeh B.C., Cohen I.K., and Yager D.R. MMP-8 is the predominant collagenase in healing wounds and nonhealing ulcers. Journal of Surgical Research 81 (1999) 189-195
17. Bailey A.J., Leaper D.J., Tarlton J.F., and Vickery C.J. Postsurgical wound progression monitored by temporal changes in the expression of matrix metalloproteinase-9. British Journal of Dermatology 137 (1997) 506-516
18. Bennett N., Burslem F., Gibson J., MacAuley S., Murphy G., Schultz G., et al. Analysis of the acute and chronic wound environments: the role of proteases and their inhibitors. Wound Repair and Regeneration 7 (1999) 442-452
19. Daebritz S., Fuchs A.T., Hammer S., Kozlik-Feldmann R., Netz H., and Rinker C. Interleukin-6 and procalcitonin in serum of children undergoing cardiac surgery with cardiopulmonary bypass. Acta Cardiologica 59 (2004) 624-629
20. Akimura T., Fujisawa H., Fujii M., Ishihara H., Kajiwara K., Kato S., et al. Increased matrix metalloproteinase-9 in blood in association with activation of interleukin-6 after traumatic brain injury: influence of hypothermic therapy. Journal of Neurotrauma 21 (2004) 1706-1711
21. Shinoda C., and Takaku S. Interleukin-1 beta, interleukin-6, and tissue inhibitor of metalloproteinase-1 in the synovial fluid of the temporomandibular joint with respect to cartilage destruction. Oral Diseases 6 (2000) 383-390
22. Cohen I.K., Diegelmann R.F., Liang H.X., Yager D.R., and Zhang L.Y. Wound fluids from human pressure ulcers contain elevated matrix metalloproteinase levels and activity compared to surgical wound fluids. Journal of Investigative Dermatology 107 (1996) 743-748
23. Konttinen T., Lauharanta J., Sorsa T., Vaheri A., and Weckroth M. Matrix metalloproteinases, gelatinase and collagenase in chronic leg ulcers. Journal of Investigative Dermatology 106 (1996) 1119-1124
24. Johansson N., Kahari V.M., Kalalainen-Lindsberg M.L., Kariniemi A.L., Mattila L., Saarialho-Kere U., et al. Distinct populations of stromal cells express collagenase-3 (MMP-13) and collagenase-1 (MMP-1) in chronic ulcers but not normally healing wounds. Journal of Investigative Dermatology 109 (1997) 96-101
25. Kere J., Lauharanta J., Puolakkainen P., Saarialho-Kere U.K., Saarinen P., Vaalamo M., et al. Patterns of matrix metalloproteinase and TIMP-1 expression in chronic and normally healing human cutaneous wounds. British Journal of Dermatology 135 (1996) 52-59
26. Barbul A., Efron D.T., Kiyama T., Moldawer L.L., Schulz G.S., Thornton F.J., et al. Metalloproteinase inhibitors and wound healing: a novel enhancer of wound strength. Surgery 124 (1998) 464-470
27. Azar D.T., and Ye H.Q. Expression of gelatinases A and B, and TIMPs 1 and 2 during corneal wound healing. Investigative Ophthalmology and Visual Science 39 (1998) 913-921
28. Fridman R., Mobashery S., Pena D., and Toth M. Activation of progelatinase B (MMP-9) by gelatinase A (MMP-2). Cancer Research 55 (1995) 2548-2555
29. Beamer R.L., Helmer S.D., McBoyle M.F., and Woodworth P.A. Seroma formation after breast cancer surgery: incidence and predicting factors. American Surgeon 66 (2000) 444-450
30. Dawson I., Heslinga J.M., Kalsbeek H.L., and Stam L. Effect of shoulder immobilization on wound seroma and shoulder dysfunction following modified radical mastectomy: a randomized prospective clinical trial. The British Journal of Surgery 76 (1989) 311-312
31. Hattori S., Kobayashi T., Nagai Y., Nishikawa T., and Tajima S. Differential regulation of MMP-2 and MMP-9 gelatinases in cultured human keratinocytes. Dermatology 197 (1998) 1-5
32. Budd D.C., Cochran R.C., Fouty W.J., and Sturtz D.L. Surgical morbidity after mastectomy operations. American Journal of Surgery 135 (1978) 218-220
33. Jolly P.C., and Viar W. Reduction of morbidity after radical mastectomy. American Surgeon 47 (1981) 377-380
34. Arleth A.J., Barone F.C., Ohlstein E.H., Romanic A.M., and White R.F. Matrix metalloproteinase expression increases after cerebral focal ischemia in rats: inhibition of matrix metalloproteinase-9 reduces infarct size. Stroke 29 (1998) 1020-1030